On 12 October 2015, World Arthritis Day, a Research and Information Day, “Together against Arthritis” will be held at Espace Charenton, Paris, under the patronage of Mr François Hollande, President of France.
Announced at the end of 2014 during the final phase of research and development, the rapid diagnostic test for Ebola virus disease developed by the French Atomic Energy Commission (CEA), with support from the Inserm Jean Mérieux P4 high-level biological containment laboratory (Lyon), has been assessed in the field, including in Guinea, over a period of several months.
Inserm is pleased to have awarded its 2008 International Prize to Tomas Lindahl, who was today awarded the 2015 Nobel Prize in Chemistry.
The Nobel prize in physiology or medecine is awarded to William C. Campbell et Satoshi Ōmura et Youyou Tu
On the occasion of Prime Minister Valls’ visit and the launch of the France-Japan Year of Innovation, Inserm signs a research partnership with St Luke’s International University to combat Ebola virus.
By drawing on seismology, Inserm researcherhave just developed a noninvasive brain imaging method using MRI that provides the same information as physical palpation.
Researchers have analysed data on pre- and postnatal exposure to tobacco in the homes of 5,200 primary school children. They show that this exposure is associated with a risk of behavioural disorders in children, particularly emotional and conduct disorders.
Researchers from Inserm and University of Bordeaux have just discovered that the cannabinoid receptors of the brain control these memories that are crucial for survival.
Des scientifiques provenant de 6 pays, réunis au sein du projet ENS@T-HT mettent en commun leur expertise afin d’améliorer le diagnostic et la prise en charge thérapeutique de l’hypertension artérielle primaire et secondaire par une approche axée sur les « omiques ». Le projet ENS@T-HT, coordonné par Maria-Christina Zennaro, Directrice de recherche à l’Inserm (Centre de recherche Cardiovasculaire de Paris), a été officiellement lancé ce mois-ci à Paris et...
The twin objective of this new collaboration between the French National Institute of Health and Medical Research (Inserm) and CentraleSupélec is to train engineers that are better integrated into research laboratories, and biologists that are more involved in technological innovation.
